PSTI |
Pluristem's PLX-PAD Cells' safety in human lung models shown by research study Pluristem Therapeutics announced that independent researchers from the Queensland Lung Transplant Service at the University of Queensland, Australia demonstrated that following infusion of Pluristem's PLX cells in a human lung model of pulmonary arterial hypertension, or PAH, blood flows were maintained and no adverse hemodynamic effects were noted. |